# Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study

Study · id `cardio:ct-nct06078735` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06078735](<https://clinicaltrials.gov/study/NCT06078735>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06078735

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 110 participants.

## Technical summary

Registry record NCT06078735. Randomized; no masking; primary purpose supportive care. Start 2023-10-02 (actual); primary completion 2024-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT06078735, source copy `cardio:ctgov-nct06078735-2024-10-29`, retrieved 2026-11-18)
- Started: 2023-10-02 (actual) (ClinicalTrials.gov record NCT06078735, source copy `cardio:ctgov-nct06078735-2024-10-29`, retrieved 2026-11-18)
- Primary completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT06078735, source copy `cardio:ctgov-nct06078735-2024-10-29`, retrieved 2026-11-18)
- Completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT06078735, source copy `cardio:ctgov-nct06078735-2024-10-29`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT06078735, source copy `cardio:ctgov-nct06078735-2024-10-29`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06078735-2024-10-29`, retrieved 2026-11-18)

## The registry's words

- Brief title: Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
- Condition: Atrial Fibrillation
- Condition: Hemostasis
- Intervention (Device): Vascular closure with LockeT device
- Lead sponsor: Kansas City Heart Rhythm Research Foundation
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Kansas City Heart Rhythm Research Foundation (`cardio:org-kansas-city-heart-rhythm-research-foundation`)

## Provenance

Content hash: 5b2c5b0d966ebdb7411a61fa5ff77084d6821fe308e16b21e02bfe453d3596bf
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
